The NIH defines Diversity and Inclusion in Clinical Trials as a type of clinical research that evaluates the effects of intervention(s), including drugs, devices, surgeries, diets, behavioral approaches, and lifestyle interventions, on health-related biomedical or behavioral outcomes. It is known that while there are common features of each disease, individuals experience the same disease differently.
The culture of the individual and their lived experiences impact how they experience the disease and their genotype and phenotype may impact how they respond to different medicines and other treatments. In order for us to improve the health and well-being of all human beings, it is imperative to ensure that clinical trials include people from a variety of characteristics like race/ethnicity, age, gender, and sexual orientation, so that all communities can benefit most rapidly from medical research. Responding to this need, we have created and validated training to help all researchers engage respectfully with persons from diverse backgrounds and successfully recruit them into clinical trials. This work has been funded in part by grants from the American Heart Association and the National Institute on Aging.
Our research has identified factors that are barriers and facilitators to diversifying clinical trials